Skip to main content
RNAC
NASDAQ Life Sciences

Descartes-08 Retreatment Data Shows 6.6-Point MG-ADL Reduction at Month 12

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$7.24
Mkt Cap
$218.141M
52W Low
$5.6
52W High
$11
52W Position info
29% above low
Off High info
34% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

RNAC sits 29% above its 52-week low of $5.6.

Summary

Cartesian Therapeutics released additional retreatment data for Descartes-08 in myasthenia gravis, showing a mean MG-ADL reduction of 6.6 points at month 12 post retreatment. The median interval between initial treatment and retreatment infusion was 16.6 months, indicating durable responses. No new safety signals were reported. The company also provided updated regulatory timelines: topline data from the Phase 3 AURORA trial is expected in 1Q27, with a BLA filing anticipated in mid-2027. This follows the Q2 2026 earnings report in August, which highlighted a cash runway into 2028. The data supports the potential of Descartes-08 as a meaningful treatment option, and the upcoming Phase 3 readout will be a key milestone.

At the time of this announcement, RNAC was trading at $7.24 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $218.1M. The 52-week trading range was $5.60 to $11.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

RNAC - Latest Insights

RNAC
Nov 05, 2026, 9:32 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $6.86
Real-time Price: $6.49 info
Change: -$0.3674 (-5%) info
Market Cap: $185.458M info
RNAC
Aug 06, 2026, 7:05 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $8.26
Real-time Price: $6.49 info
Change: -$1.77 (-21%) info
Market Cap: $185.458M info
RNAC
Aug 06, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $8.26
Real-time Price: $6.49 info
Change: -$1.77 (-21%) info
Market Cap: $185.458M info
RNAC
Jun 09, 2026, 7:16 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.40
Real-time Price: $6.49 info
Change: +$0.0876 (+1%) info
Market Cap: $185.458M info
RNAC
Jun 09, 2026, 7:01 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $6.34
Real-time Price: $6.49 info
Change: +$0.1476 (+2%) info
Market Cap: $185.458M info